(Q43731177)

26 November 2017

title

Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications (English)

1 reference

attention deficit hyperactivity disorder

26 November 2017

main subject

1 reference

Tim A Bruckner

1

1 reference

26 November 2017

Ashley Hodgson

2

1 reference

26 November 2017

Chris Brown Mahoney

3

1 reference

26 November 2017

Brent D Fulton

4

1 reference

26 November 2017

Peter Levine

5

1 reference

26 November 2017

Richard M Scheffler

6

1 reference

26 November 2017

publication date

24 October 2011

1 reference

Pharmacoepidemiology and Drug Safety

26 November 2017

published in

1 reference

26 November 2017

volume

21

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

442-449

1 reference

Diagnosis and treatment of behavioral health disorders in pediatric practice

26 November 2017

cites work

1 reference

Child mental health and human capital accumulation: the case of ADHD.

21 January 2018

1 reference

Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence.

21 January 2018

1 reference

Childhood psychiatric disorder and unintentional injury: findings from a national cohort study.

21 January 2018

1 reference

Trends in the use of psychotropic medications among adolescents, 1994 to 2001.

21 January 2018

1 reference

ADHD and the Rise in Stimulant Use Among Children

21 January 2018

1 reference

Identification of attentional and hyperactivity problems in primary care: a report from pediatric research in office settings and the ambulatory sentinel practice network

21 January 2018

1 reference

Knowledge and information about ADHD: evidence of cultural differences among African-American and white parents.

21 January 2018

1 reference

Neighbourhood socioeconomic disadvantage and behavioural problems from late childhood into early adolescence.

21 January 2018

1 reference

The relative importance of child, family, school and neighbourhood correlates of childhood psychiatric disorder

21 January 2018

1 reference

Clinical practice. Attention deficit-hyperactivity disorder

21 January 2018

1 reference

Unwarranted variations in healthcare delivery: implications for academic medical centres

21 January 2018

1 reference

The use of methylphenidate in Michigan

21 January 2018

1 reference

The global market for ADHD medications.

21 January 2018

1 reference

Race/ethnicity and insurance status as factors associated with ADHD treatment patterns

21 January 2018

1 reference

The incidence of methylphenidate use by Canadian children: what is the impact of socioeconomic status and urban or rural residence?

21 January 2018

1 reference

An analysis of the significant variation in psychostimulant use across the U.S.

21 January 2018

1 reference

Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample

21 January 2018

1 reference

Who receives a diagnosis of attention-deficit/ hyperactivity disorder in the United States elementary school population?

21 January 2018

1 reference

Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity

21 January 2018

1 reference

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.2264

1 reference

release_msa6h7nvl5c7bbjfgj7to2cjma

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/msa6h7nvl5c7bbjfgj7to2cjma

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference